# Fennec Pharmaceuticals Inc.: Form 8-K, filed May 18, 2026

- Company: [Fennec Pharmaceuticals Inc.](/companies/fenc.md) (CIK 1211583)
- Form: 8-K
- Filed: 2026-05-18
- Accepted by EDGAR: May 18, 2026, 17:12 ET
- Period: 2026-05-18
- Accession: 0001104659-26-063271
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1211583/000110465926063271/fencf-20260518x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1211583/000110465926063271/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1211583/000110465926063271/fencf-20260518x8k.htm

Filed May 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-063271. Last ingested by Listed: Nov 2, 2026, 19:14 ET. No prices; not investment advice.